208 related articles for article (PubMed ID: 27035150)
1. Pretreatment with Fucoidan from Fucus vesiculosus Protected against ConA-Induced Acute Liver Injury by Inhibiting Both Intrinsic and Extrinsic Apoptosis.
Li J; Chen K; Li S; Liu T; Wang F; Xia Y; Lu J; Zhou Y; Guo C
PLoS One; 2016; 11(4):e0152570. PubMed ID: 27035150
[TBL] [Abstract][Full Text] [Related]
2. Salvianolic acid A preconditioning confers protection against concanavalin A-induced liver injury through SIRT1-mediated repression of p66shc in mice.
Xu X; Hu Y; Zhai X; Lin M; Chen Z; Tian X; Zhang F; Gao D; Ma X; Lv L; Yao J
Toxicol Appl Pharmacol; 2013 Nov; 273(1):68-76. PubMed ID: 23993977
[TBL] [Abstract][Full Text] [Related]
3. Fucoidan from Fucus vesiculosus attenuates doxorubicin-induced acute cardiotoxicity by regulating JAK2/STAT3-mediated apoptosis and autophagy.
Zhang J; Sun Z; Lin N; Lu W; Huang X; Weng J; Sun S; Zhang C; Yang Q; Zhou G; Guo H; Chi J
Biomed Pharmacother; 2020 Oct; 130():110534. PubMed ID: 32711244
[TBL] [Abstract][Full Text] [Related]
4. Apoptosis inducing activity of fucoidan in HCT-15 colon carcinoma cells.
Hyun JH; Kim SC; Kang JI; Kim MK; Boo HJ; Kwon JM; Koh YS; Hyun JW; Park DB; Yoo ES; Kang HK
Biol Pharm Bull; 2009 Oct; 32(10):1760-4. PubMed ID: 19801840
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of concanavalin A-induced cytokine synthesis by hepatic stellate cells: Distinct roles of interferon regulatory factor-1 in liver injury.
Rani R; Kumar S; Sharma A; Mohanty SK; Donnelly B; Tiao GM; Gandhi CR
J Biol Chem; 2018 Nov; 293(48):18466-18476. PubMed ID: 30348900
[TBL] [Abstract][Full Text] [Related]
6. Shikonin Attenuates Concanavalin A-Induced Acute Liver Injury in Mice via Inhibition of the JNK Pathway.
Liu T; Xia Y; Li J; Li S; Feng J; Wu L; Zhang R; Xu S; Cheng K; Zhou Y; Zhou S; Dai W; Chen K; Wang F; Lu J; Zhou Y; Guo C
Mediators Inflamm; 2016; 2016():2748367. PubMed ID: 27293314
[TBL] [Abstract][Full Text] [Related]
7. Fucoidan from Fucus vesiculosus protects against alcohol-induced liver damage by modulating inflammatory mediators in mice and HepG2 cells.
Lim JD; Lee SR; Kim T; Jang SA; Kang SC; Koo HJ; Sohn E; Bak JP; Namkoong S; Kim HK; Song IS; Kim N; Sohn EH; Han J
Mar Drugs; 2015 Feb; 13(2):1051-67. PubMed ID: 25690093
[TBL] [Abstract][Full Text] [Related]
8. Protective effects of a traditional Chinese herbal formula Jiang-Xian HuGan on Concanavalin A-induced mouse hepatitis via NF-κB and Nrf2 signaling pathways.
Tang HH; Li HL; Li YX; You Y; Guan YY; Zhang SL; Liu LX; Bao WL; Zhou Y; Shen XY
J Ethnopharmacol; 2018 May; 217():118-125. PubMed ID: 29421593
[TBL] [Abstract][Full Text] [Related]
9. Taraxasterol from
Sang R; Yu Y; Ge B; Xu L; Wang Z; Zhang X
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3929-3937. PubMed ID: 31571510
[TBL] [Abstract][Full Text] [Related]
10. Fucoidan from Fucus vesiculosus suppresses hepatitis B virus replication by enhancing extracellular signal-regulated Kinase activation.
Li H; Li J; Tang Y; Lin L; Xie Z; Zhou J; Zhang L; Zhang X; Zhao X; Chen Z; Zuo D
Virol J; 2017 Sep; 14(1):178. PubMed ID: 28915824
[TBL] [Abstract][Full Text] [Related]
11. Pretreatment with dihydroquercetin, a dietary flavonoid, protected against concanavalin A-induced immunological hepatic injury in mice and TNF-α/ActD-induced apoptosis in HepG2 cells.
Chen J; Sun X; Xia T; Mao Q; Zhong L
Food Funct; 2018 Apr; 9(4):2341-2352. PubMed ID: 29589006
[TBL] [Abstract][Full Text] [Related]
12. Alpha-amylase and alpha-glucosidase inhibition is differentially modulated by fucoidan obtained from Fucus vesiculosus and Ascophyllum nodosum.
Kim KT; Rioux LE; Turgeon SL
Phytochemistry; 2014 Feb; 98():27-33. PubMed ID: 24388677
[TBL] [Abstract][Full Text] [Related]
13. Fucoidan from Sargassum sp. and Fucus vesiculosus reduces cell viability of lung carcinoma and melanoma cells in vitro and activates natural killer cells in mice in vivo.
Ale MT; Maruyama H; Tamauchi H; Mikkelsen JD; Meyer AS
Int J Biol Macromol; 2011 Oct; 49(3):331-6. PubMed ID: 21624396
[TBL] [Abstract][Full Text] [Related]
14. Protective effect of fucoidan from Fucus vesiculosus on liver fibrosis via the TGF-β1/Smad pathway-mediated inhibition of extracellular matrix and autophagy.
Li J; Chen K; Li S; Feng J; Liu T; Wang F; Zhang R; Xu S; Zhou Y; Zhou S; Xia Y; Lu J; Zhou Y; Guo C
Drug Des Devel Ther; 2016; 10():619-30. PubMed ID: 26929597
[TBL] [Abstract][Full Text] [Related]
15. Preclinical Evaluation of Safety of Fucoidan Extracts From Undaria pinnatifida and Fucus vesiculosus for Use in Cancer Treatment.
Mathew L; Burney M; Gaikwad A; Nyshadham P; Nugent EK; Gonzalez A; Smith JA
Integr Cancer Ther; 2017 Dec; 16(4):572-584. PubMed ID: 29096568
[TBL] [Abstract][Full Text] [Related]
16. [Effect of ronggan mixture on immunoregulation and hepatocyte apoptosis-related factors in concanavalin A induced acute immunological liver injury mice].
Zhang YQ; Tang XD; Wang FY; Yang B; Liu YL; Guo P; Wang P; Bian LQ; Zhao YP
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2013 Nov; 33(11):1500-6. PubMed ID: 24483111
[TBL] [Abstract][Full Text] [Related]
17. Anti-Metabolic Syndrome Effects of Fucoidan from
Wang X; Shan X; Dun Y; Cai C; Hao J; Li G; Cui K; Yu G
Molecules; 2019 Sep; 24(18):. PubMed ID: 31547311
[TBL] [Abstract][Full Text] [Related]
18. Ghrelin reduces liver impairment in a model of concanavalin A-induced acute hepatitis in mice.
Mao Y; Wang J; Yu F; Cheng J; Li H; Guo C; Fan X
Drug Des Devel Ther; 2015; 9():5385-96. PubMed ID: 26451091
[TBL] [Abstract][Full Text] [Related]
19. Fucoidan Inhibition of Osteosarcoma Cells Is Species and Molecular Weight Dependent.
Gupta D; Silva M; Radziun K; Martinez DC; Hill CJ; Marshall J; Hearnden V; Puertas-Mejia MA; Reilly GC
Mar Drugs; 2020 Feb; 18(2):. PubMed ID: 32046368
[TBL] [Abstract][Full Text] [Related]
20. CGX, a traditional Korean medicine ameliorates concanavalin A-induced acute liver injury.
Shin JW; Wang JH; Kim HG; Park HJ; Bok HS; Son CG
Food Chem Toxicol; 2010 Dec; 48(12):3308-15. PubMed ID: 20800087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
